Literature DB >> 8407960

Deletion of a large domain in recombinant human procollagen II does not alter the thermal stability of the triple helix.

A L Sieron1, A Fertala, L Ala-Kokko, D J Prockop.   

Abstract

A construct of the human gene for procollagen II (COL2A1) was prepared with an internal deletion of 5 kilobases that removed 12 exons coding for 291 amino acids from near the NH2 terminus of the triple helix. The construct was then used to transfect stably a human tumor cell line (HT-1080), and clones secreting internally deleted pro alpha 1(II) chain of procollagen II were isolated. The protein was purified, and the thermal stability of the triple-helical domain was assayed by brief protease digestion. The thermal stability of the internally deleted protein was the same as that of intact collagen II even though the triple helix was 39% shorter. Additionally, the thermal stability of the collagenase A fragment was the same as that of the collagenase A fragment of normal collagen II even though it was 38% shorter. Analysis of the results suggested that the thermal stabilities of large fragments of collagen II depended primarily on their contents of -Gly-Pro-Hyp-triplets corrected for length.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407960

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice.

Authors:  L K Myers; D D Brand; X J Ye; M A Cremer; E F Rosloniec; M Bodo; J Myllyharju; T Helaakoski; M Nokelainen; T Pihlajaniemi; K Kivirikko; C L Yang; L Ala-Kokko; D J Prockop; H Notbohm; P Fietzek; J M Stuart; A H Kang
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

3.  Dissecting a bacterial collagen domain from Streptococcus pyogenes: sequence and length-dependent variations in triple helix stability and folding.

Authors:  Zhuoxin Yu; Barbara Brodsky; Masayori Inouye
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

4.  Reducing the effects of intracellular accumulation of thermolabile collagen II mutants by increasing their thermostability in cell culture conditions.

Authors:  Katarzyna Gawron; Deborah A Jensen; Andrzej Steplewski; Andrzej Fertala
Journal:  Biochem Biophys Res Commun       Date:  2010-04-13       Impact factor: 3.575

5.  Targeted insertions of two exogenous collagen genes into both alleles of their endogenous loci in cultured human cells: the insertions are directed by relatively short fragments containing the promoters and the 5' ends of the genes.

Authors:  A Ganguly; S Smelt; R Mewar; A Fertala; A L Sieron; J Overhauser; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix.

Authors:  Joanna Witecka; Aleksandra M Auguściak-Duma; Anna Kruczek; Anna Szydło; Marta Lesiak; Maria Krzak; Jacek J Pietrzyk; Minna Männikkö; Aleksander L Sieroń
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

7.  R992C (p.R1192C) Substitution in collagen II alters the structure of mutant molecules and induces the unfolded protein response.

Authors:  Hye Jin Chung; Deborah A Jensen; Katarzyna Gawron; Andrzej Steplewski; Andrzej Fertala
Journal:  J Mol Biol       Date:  2009-05-08       Impact factor: 5.469

8.  Substitution of aspartic acid for glycine at position 310 in type II collagen produces achondrogenesis II, and substitution of serine at position 805 produces hypochondrogenesis: analysis of genotype-phenotype relationships.

Authors:  J Bonaventure; L Cohen-Solal; P Ritvaniemi; L Van Maldergem; N Kadhom; A L Delezoide; P Maroteaux; D J Prockop; L Ala-Kokko
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.